2022 Sep 30, 2022 R&D Announcement: Commencement of Phase II Clinical Trials for Janus Kinase Inhibitor "ROH-201" in Japan Sep 27, 2022 Management ROHTO Pharmaceutical's Mother Plant, Ueno Techno Center, Commences Operations of New Facility Sep 26, 2022 Sustainability Announcement Regarding the Acquisition of Full Ownership of Naris Cosmetics Vietnam Co., Ltd. by ROHTO Mentholatum (Vietnam) Co., Ltd. Jun 22, 2022 Management Announcement of Joint Venture Establishment for Advancing Regenerative Medicine Business in China Mar 28, 2022 R&D Notice of Commencement of Domestic Phase I Clinical Trial for Ophthalmic Therapeutic Agent "ROH-202" Mar 24, 2022 Management Participation in the Osaka Pavilion at the 2025 World Exposition in Japan (Osaka and Kansai Exposition) News ReleaseRSS